FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33528311000001103: Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 16-Aug 2017. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    101049301000001113 Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    104524601000001113 Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) Is a Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution sugar free false Inferred relationship Existential restriction modifier
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) Has active ingredient Sodium chloride false Inferred relationship Existential restriction modifier
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) VMP non-availability indicator Re-introduced false Inferred relationship Existential restriction modifier
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) Has specific active ingredient Sodium chloride false Inferred relationship Existential restriction modifier
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) Has dispensed dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) Is a Syrisal false Inferred relationship Existential restriction modifier
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) 100 ml (product) Has AMP False Syrisal 292.5mg/5ml (1mmol/ml) oral solution (Thame Laboratories) (product) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start